Clinical Trial

Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress

Study acronym: ASPIRE-AF
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Multinational, investigator-initiated study of oral anticoagulation versus no anticoagulation for the prevention of stroke and other adverse cardiovascular events in patients with transient atrial fibrillation occurring transiently with stress and additional stroke risk factors.
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2019-05-27; most recent amendment 2026-01-08.
Status change: Not Yet Recruiting → Recruiting 2019-07-22
Trial Details
NCT Number NCT03968393
Lead Sponsor Population Health Research Institute
Collaborators: Hamilton Health Sciences Corporation
Conditions Stroke, Atrial Fibrillation
Enrollment 2,270 participants
Start Date 2019-06-14
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-12